Nolet Chris
Transaction: 06/18/2026
BUY
Change
+13,562
Price
$31.74
Filing
06/22/2026
Type
BUY
ArriVent BioPharma, Inc.
AVBP • Biotechnology
$30.95
▼ -0.08 (-0.26%)
Current price
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$1.52B
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 12.83Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 11, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$30.95
Change-0.26%
Market Cap$1.52B
52W Range16.10 - 34.06
Beta0.88
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio12.83
Quick Ratio12.83
Target$45.00
Price$30.95
Change-0.26%
Market Cap$1.52B
52W Range16.10 - 34.06
Beta0.88
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio12.83
Quick Ratio12.83
Target$45.00
Target Upside45.40%
Target Median$45.00
Target Range45.00 - 45.00
Volume729.20K
Avg Volume491.13K
EPS Surprise-0.08
Investment DNA
How strong this company looks for long-term investors
45
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
82/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 12.83Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-06-23
Low
$45.00
Mean
$45.00
Median
$45.00
High
$45.00
Insider Transactions
Recent executive and insider activity
⚠ 3 high-volume insider sells detected
Hohneker John
Transaction: 06/18/2026
BUY
Change
+13,562
Price
$31.74
Filing
06/22/2026
Type
BUY
Peterson Kristine
Transaction: 06/18/2026
BUY
Change
+13,562
Price
$31.74
Filing
06/22/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Nolet Chris | BUY | +13,562 | $31.74 | 06/18/2026 | 06/22/2026 |
| Hohneker John | BUY | +13,562 | $31.74 | 06/18/2026 | 06/22/2026 |
| Peterson Kristine | BUY | +13,562 | $31.74 | 06/18/2026 | 06/22/2026 |
| Parsey Merdad | BUY | +13,562 | $31.74 | 06/18/2026 | 06/22/2026 |
| Kastenmayer James Paul | BUY | +130,000 | $22.67 | 02/02/2026 | 02/04/2026 |
| Yao Zhengbin | BUY | +550,000 | $22.67 | 02/02/2026 | 02/04/2026 |
| Kung Winston | BUY | +140,000 | $22.67 | 02/02/2026 | 02/04/2026 |
| Lutzker Stuart | BUY | +150,000 | $22.67 | 02/02/2026 | 02/04/2026 |
| LaChapelle Robin | BUY | +130,000 | $22.67 | 02/02/2026 | 02/04/2026 |
| HILLHOUSE INVESTMENT MANAGEMENT, LTD. | SELL | -555,555 | $23.37 | 12/10/2025 | 02/03/2026 |
| LaChapelle Robin | SELL | -2,050 | $2.28 | 07/11/2025 | 07/15/2025 |
| LaChapelle Robin | BUY | +2,050 | $2.28 | 07/11/2025 | 07/15/2025 |
| Nolet Chris | BUY | +15,502 | $24.89 | 06/18/2025 | 06/20/2025 |
| Hohneker John | BUY | +15,502 | $24.89 | 06/18/2025 | 06/20/2025 |
| Peterson Kristine | BUY | +15,502 | $24.89 | 06/18/2025 | 06/20/2025 |
| Parsey Merdad | BUY | +15,502 | $24.89 | 06/18/2025 | 06/20/2025 |
| Parsey Merdad | OTHER | 0 | Not reported | 04/28/2025 | 04/29/2025 |
| Parsey Merdad | BUY | +28,346 | $20.92 | 04/28/2025 | 04/29/2025 |
| HILLHOUSE INVESTMENT MANAGEMENT, LTD. | SELL | -55,000,000 | Not reported | 01/30/2024 | 02/01/2024 |
| HILLHOUSE INVESTMENT MANAGEMENT, LTD. | SELL | -4,761,903 | Not reported | 01/30/2024 | 02/01/2024 |